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The vas deferens receives a dense sympathetic innervation
(see Stjärne, 1989). Following nerve stimulation, the
co-transmitters ATP (Burnstock, 1976; Morris & Gibbins,
1992), which acts on P2X1 receptors (Mulryan et al. 2000),
and noradrenaline (NA), which acts on a1-adrenoceptors,
are released. P2X1 receptors are ligand-gated cation
channels that are permeable to cations including Ca2+
(Benham & Tsien, 1987). In contrast, a1-adrenoceptors
are G protein coupled and their activation in many smooth
muscle cells leads to the production of inositol tris-
phosphate (IP3), which in turn releases Ca
2+ from intra-
cellular stores (Hashimoto et al. 1986). Given that the two
principal co-transmitters in the vas deferens are generally
assumed to increase Ca2+ concentration ([Ca2+]) in smooth
muscle cells, the measurement of postjunctional [Ca2+]
provides a potential approach for the detection of transmitter
release with a high spatial and temporal resolution.
Transmitter release from autonomic nerve terminals
following nerve stimulation has previously been detected
by measuring either contraction, the overflow of transmitters
or their metabolites (Loewi, 1936; Peart, 1949; Brown &
Gillespie, 1957), intracellular recording of junction potentials
(Burnstock & Holman, 1961), focal extracellular recording
of excitatory junctional currents (Brock & Cunnane, 1987,
1988) or amperometry (Mermet et al. 1990). These
techniques have allowed the measurement of the average
release probability per action potential per varicosity, and
have shown that transmitter release is highly intermittent
at neuroeffector junctions. By measuring transmitter
overflow and counting the number of varicosities per unit
volume of smooth muscle, the average probability of
release was first estimated to be 0.01–0.03 (Folkow et al.
1967). Very similar probabilities (0.002–0.03; Cunnane &
Stjärne, 1984) were determined by measuring ‘discrete
events’ in excitatory junction currents. These release
probabilities are, however, considerably lower than those
determined from measurement of focal extracellular
currents using small diameter electrodes (mean probability
of 0.25; Lavidis & Bennett, 1992). The discrepancies among
measurements of release probability may arise because of
the significant difficulties involved in estimating the
number of release sites that are sampled with each
technique. Hence a technique that enables the detection of
transmitter release from single varicosities would allow a
more accurate measurement of release probability.
Intermittent ATP release from nerve terminals elicits focal
smooth muscle Ca2+ transients in mouse vas deferens
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A confocal Ca2+ imaging technique has been used to detect ATP release from individual sympathetic
varicosities on the same nerve terminal branch. Varicose nerve terminals and smooth muscle cells in
mouse vas deferens were loaded with the Ca2+ indicator Oregon Green 488 BAPTA-1. Field (nerve)
stimulation evoked discrete, focal increases in [Ca2+] in smooth muscle cells adjacent to identified
varicosities. These focal increases in [Ca2+] have been termed ‘neuroeffector Ca2+ transients’
(NCTs). NCTs were abolished by a,b-methylene ATP (1 mM), but not by nifedipine (1 mM) or
prazosin (100 nM), suggesting that NCTs are generated by Ca2+ influx through P2X receptors
without a detectable contribution from L-type Ca2+ channels or a1-adrenoceptor-mediated
pathways. Action potential-evoked ATP release was highly intermittent (mean probability
0.019 ± 0.002; range 0.001–0.10) at 1 Hz stimulation, even though there was no failure of action
potential propagation in the nerve terminals. Twenty-eight per cent of varicosities failed to release
transmitter following more than 500 stimuli. Spontaneous ATP release was very infrequent
(0.0014 Hz). No Ca2+ transient attributable to noradrenaline release was detected even in response
to 5 Hz stimulation. There was evidence of local noradrenaline release as the a2-adrenoceptor
antagonist yohimbine increased the probability of occurrence of NCTs by 55 ± 21 % during trains
of stimuli at 1 Hz. Frequency-dependent facilitation preferentially occurred at low probability
release sites. The monitoring of NCTs now allows transmitter release to be detected simultaneously
from each functional varicosity on an identified nerve terminal branch on an impulse-to-impulse
basis.
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Here we report on the development of a novel technique to
detect ATP release from individual sympathetic varicosities
on the same nerve terminal branch on an impulse-to-
impulse basis. Using this technique, we have determined
the characteristic physiological and pharmacological
features of evoked and spontaneous transmitter release
from single varicosities on the same nerve terminal branch
in mouse isolated vas deferens.
METHODS 
Indicator loading
Vasa deferentia were removed from 8- to 12-week-old Balb/c mice
(Harlan, UK), which had been killed by cervical fracture. All
efforts were made to minimise the number of animals used; all
experiments were in accordance with the European Communities
Council Directives (86/609/EEC of 24 November 1986). The cut
prostatic end of the vas deferens was secured in a glass
micropipette containing the Ca2+ indicator Oregon Green 488
BAPTA-1 10 kDa dextran (Molecular Probes, OR, USA), using a
protocol similar to that previously described (Brain & Bennett,
1997). Less than 1 mm of the length of the vas deferens was drawn
into the pipette. The loading procedure filled many varicose
postganglionic nerve terminals and, within 2 mm of the cut end of
the vas deferens, a subset of smooth muscle cells. Nerve terminals
and smooth muscle cells were identified based on their
characteristic morphology. The concomitant loading of a population
of smooth muscle cells was an unexpected finding as the dextran
conjugates of Ca2+ indicators have low membrane permeability
and are unlikely to traverse the gap junctions that couple smooth
muscle cells. One possible explanation for smooth muscle cell
loading is uptake of the indicator by pinocytosis during the long
loading period.
In initial experiments, 2.5 % Triton X-100 was added to the
indicator solution, as it had been thought that this detergent
would make axons more permeable to the indicator. To avoid
permeabilisation of the smooth muscle cells, subsequent
preparations were loaded in the absence of Triton X-100. There
was no detectable diminution of indicator loading into either
nerve terminals or smooth muscle cells in the absence of
Triton X-100.
Image acquisition
Images were acquired using a Leica inverted confocal microscope.
All field stimuli (pulse width 0.06 ms; amplitude 50 V; 0.1–5 Hz)
were synchronised with the start of image acquisition, so that the
interval between each stimulus and recording was fixed. The high
stimulus voltage maximised the chance that the nerve terminal
action potential would be reliably initiated, which was particularly
important in the experiments where the nerve terminal [Ca2+]
could not be monitored. Confocal images were captured in sets of
either 60 or 200, with a 2 min interval between each set. In each
experiment, eight sets of images were recorded as controls.
Preparations were exposed to each drug under investigation for
20 min to ensure adequate equilibration, and then a further eight
sets of images were recorded. Unless stated otherwise, images were
captured at twice the stimulus frequency, so that a stimulus
occurred on every second frame. This protocol provided a control
image prior to every stimulus and hence allowed the detection of
consecutive [Ca2+] transients from the same location.
Image analysis
Image analysis was performed with NIH Image (from URL
http://rsb.info.nih.gov/nih-image/) or Image SXM (from URL
http://reg.ssci.liv.ac.uk/). Local, discrete changes in Ca2+
concentration in smooth muscle cells ([Ca2+]sm) were detected
using custom-written macros based upon the ‘Particle Analysis’
algorithm of NIH Image. From the raw images, the ratios of the
fluorescent intensity between consecutive recordings were
calculated on a pixel-by-pixel basis without any averaging of the
controls. The Particle Analysis algorithm was used to detect focal
changes in the ratio of fluorescence intensities of 50 % over a
continuous area of at least 2.5 mm2. A threshold was set, based on
the background signal of the image, below which the algorithm
did not search for events. Each event was manually checked to
confirm that there was no lateral or focal plane shifts that might
have caused over-counting; such aberrant events were manually
excluded from the analysis.
When measuring the amplitude or kinetics of a focal [Ca2+]sm
transient, the change in fluorescence signal was measured within a
rectangular region (area 20–60 mm2), which completely enclosed
the [Ca2+]sm transient. The measurement box was larger than the
area of the [Ca2+]sm transient so that the entire change in
fluorescence signal was measured even if small local contractions
shifted the position of the image laterally during the period of
recording. The effects of movement were further reduced by using
the ‘Auto Register’ facility of Image SXM, i.e. the use of a cross-
correlation algorithm, based on the fast fourier transform of each
image, to align all images in a set.
The frequency of spontaneous [Ca2+]sm transients was so low that,
when determining the probability of evoked [Ca2+]sm transients,
no correction was made for their occurrence, except for experiments
involving a,b-methylene ATP and saxitoxin.
Drugs and statistical analysis
All drugs were obtained from Sigma-Aldrich (Dorset, UK).
Saxitoxin was freshly prepared on each experimental day from
commercially available pre-packaged 10 mg lots. Other drugs were
prepared from 10 mM stock solutions, frozen in aliquots at –20 °C.
Unless otherwise stated, statistical tests are Student’s two-tailed
paired t tests. Where the term ‘abolished’ is used, the probability
was not significantly different from zero (P > 0.05).
RESULTS
Neurogenic focal [Ca2+] transients in smooth muscle
cells
When the Ca2+ concentration in the smooth muscle cells
([Ca2+]sm) was monitored during trains of nerve stimuli at
2 Hz, discrete, focal increases in [Ca2+]sm were inter-
mittently detected (Fig. 1A; see the Supplementary material
data for an animation of more of this image set; number of
smooth muscle cells, nsm = 194; number of preparations,
np = 30). Each of these focal [Ca
2+]sm transients was
synchronous with a field stimulus (nsm = 194; np = 30). The
focal [Ca2+]sm transients were spatially clustered within
each smooth muscle cell. The distance between the clusters
of focal [Ca2+]sm transients was similar to the distance
between nerve terminal varicosities on the same nerve
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terminal branch. Saxitoxin, which blocks voltage-gated
Na+ channels and hence blocks the nerve terminal action
potential, abolished the electrically evoked [Ca2+]sm
transients (100 nM; number of clusters, nc = 31; nsm = 6;
np = 3).
Simultaneous measurement of [Ca2+] transients in
nerve and smooth muscle
In some preparations, regions could be found in which
both the nerve terminal varicosities and the underlying
smooth muscle cell were labelled with the Ca2+ indicator.
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Figure 1. Discrete and intermittent smooth muscle [Ca2+] transients follow nerve stimulation
A, the first six frames show selected images of the same smooth muscle cell taken during 2 Hz stimulation (#).
There is no response to most stimuli (frame 1). Other stimuli evoke focal [Ca2+] transients in the smooth
muscle cell (frames 2–6). Green represents the fluorescence of the Ca2+ indicator Oregon Green 488
BAPTA-1. The final frame was obtained from a confocal section 3 mm above that of the preceding images,
and shows an overlying nerve terminal varicosity (also filled with the indicator). Each red dot denotes the
location (centre) of a single smooth muscle [Ca2+] transient occurring at some time during 8 sets of
recordings. B, consecutive confocal images of a smooth muscle cell and an adjacent nerve terminal. Field
(nerve) stimulation occurred at 1 Hz. Following every stimulus the nerve terminal showed an increase in
[Ca2+]. Discrete Ca2+ transients (*) are occasionally detected in the smooth muscle cell. C, the relative change
in fluorescence intensity of the Ca2+ indicator in the region marked in B monitored over time. The first
significant event in B (frame 4) corresponds to the first significant event in C. D, map of the occurrence of
smooth muscle [Ca2+] transients in a different preparation. E, the probability of evoking a focal [Ca2+]
transient adjacent to these varicosities, as numbered in D.
Nerve terminals and smooth muscle cells could be
distinguished on the basis of their characteristic size, shape
and differences in the resting fluorescence (Fig. 1A, B and
D). In such preparations it is likely that there were nearby
nerve terminals that were unlabelled or poorly labelled
with the indicator. Following field stimulation, [Ca2+]
transients in varicose nerve terminals ([Ca2+]v) were
elicited in response to every action potential (Fig. 1B), as
previously reported (Brain & Bennett, 1997; Brain et al.
2001). In favourable circumstances, nerve terminal branches
traversing the long axis of a smooth muscle cell were
aligned within the focal plane of the microscope. In such
smooth muscle cells, the focal [Ca2+]sm transients arose in
direct apposition to indicator-filled varicosities (Fig. 1B,
frames 4 and 6; Fig. 1D and E). As these intermittent, focal
[Ca2+]sm transients occur immediately adjacent to nerve
terminal varicosities it is likely that they are generated by
the intermittent release of transmitter from the same
varicosities. These evoked, intermittent, focal [Ca2+]sm
transients have been termed ‘neuroeffector Ca2+ transients’
(NCTs). NCTs arising from the same tightly grouped
cluster are attributed to the focal release of transmitter
from a single varicosity, which presumably makes close
contact with the smooth muscle cell and forms a
neuroeffector junction.
Probability of release from a single varicosity
By measuring the probability of evoking an NCT in an
identified cluster it is possible to estimate the probability of
transmitter release from a single varicosity. The mean
probability of detecting an NCT at a junction following a
nerve action potential (PNCT) was 0.019 ± 0.002, with the
distribution skewed towards low probabilities (range
0.001–0.10; number of clusters, nc = 195; nsm = 28; np = 18;
mean ± S.E.M. for all results). Interestingly, at most junctions
the probability of occurrence was less than 0.01 (Fig. 2A).
The probability of occurrence of NCTs varied from
varicosity to varicosity on the same nerve terminal branch
(Fig. 1E). The probability of occurrence of NCTs from
junctions in which the overlying varicosity was filled with
the indicator (nc = 16; nsm = 6; np = 6) was not significantly
lower than in junctions where no nearby indicator-filled
varicosity could be identified (DPNCT = _0.002 ± 0.004;
one-tailed unpaired t test, P = 0.63), although this
experiment does not have sufficient statistical power to
detect a 25 % change in PNCT.
Nature of the transmitter generating NCTs
The competitive a1-adrenoceptor antagonist prazosin
(100 nM) had no effect on PNCT (DPNCT = 0.001 ± 0.002;
Fig. 2B; nc = 63; nsm = 9; np = 5; P = 0.25) and no effect on
the amplitude of NCTs (increased by 12 ± 32 %; Fig. 2C;
nc = 6; nsm = 3; np = 2). In cells previously exposed to
prazosin, bath application of a,b-methylene ATP (1 mM),
which desensitises P2X receptors, abolished NCTs
(Fig. 2B; nc = 40; nsm = 6; np = 3). In the presence ofa,b-methylene ATP (1 mM) alone, NCTs were also abolished
(nc = 57; nsm = 8; np = 4) and indeed no change in the
[Ca2+]sm was detected. The first exposure of the preparation
to a,b-methylene ATP did not elicit any detectable
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Figure 2. Neuroeffector Ca2+ transients reflect
intermittent ATP release
A, NCT probability per junction when stimulated at 1 Hz
(np = 13). B,  average NCT probability per junction in a single
smooth muscle cell as nifedipine (1 mM), then prazosin (100 nM)
and finally a,b-methylene ATP (1 mM) were added. Only the latter
drug abolished these events, although this took up to 1 h.
C, average change in fluorescence signal during NCTs from a single
junction (•; n = 6 NCTs). The time of detection of each NCT was
set to 0 s. The temporal resolution of xy-scanning (214 ms) is such
that the time of stimulus, the peak of the response, and the time of
detection, are synchronous. Nifedipine (1; n = 17) and then
prazosin (0; n = 12) had no significant effect on the amplitude.
[Ca2+]sm change. It should be noted that the bath application
of a,b-methylene ATP does not in any way mimic the
rapid, focal, high ATP concentration that follows nerve
stimulation.
It was surprising that no change in [Ca2+]sm was detected in
the presence of a,b-methylene ATP, as noradrenergic
transmission should be intact and NA is widely believed to
trigger contraction by elevating [Ca2+]sm. In order to increase
the effective junctional concentration of NA, the
catecholamine transporter uptake-1 was blocked using
desmethylimipramine. In the presence of a,b-methylene
ATP (1 mM) and desmethylimipramine (1 mM), no significant
change in [Ca2+]sm was detected during trains of stimuli at
5 Hz for 30 s (nsm = 5; np = 3). Higher frequency stimulation
was attempted, but the data could not be reliably interpreted
as the smooth muscle cells moved out of the plane of focus
as the vas deferens contracted. Whether the smooth
muscle cells under investigation contracted, or whether
other cells within the vas deferens contracted, could not be
determined.
It may be that the activation of P2X receptors is necessary,
but not sufficient, for the generation of NCTs. For
example, influx of Na+ through P2X receptors may locally
depolarise the smooth muscle cell and activate voltage-
gated Ca2+ channels. In order to test this hypothesis the
L-type Ca2+ channel blocker nifedipine was used (Fig. 2B
and C). Nifedipine (1 mM) had no effect on the probability
of evoking NCTs (DPNCT) = 0.001 ± 0.001; nc = 40; nsm = 6;
np = 3; P = 0.45) and no effect on their amplitude (increased
by 11 ± 23 %; nc = 6; nsm = 3; np = 2).
The occurrence of NCTs adjacent to stimulated
varicosities, and their clustering, intermittence and sensitivity
to a,b-methylene ATP, strongly indicates that NCTs are
elicited by the focal release of ATP from individual
varicosities.
Correlating nerve terminal [Ca2+]v transients with
NCTs
Some varicosities (28 % of 50; nsm = 8; np = 7) showed no
adjacent NCTs in response to trains of more than 500
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Figure 3. Line scanning confocal microscopy simultaneously monitors nerve terminal [Ca2+]v
and NCTs
A, xy-scan showing the position (dashed line) of the line scan images through a smooth muscle cell (sm) and
an overlying varicosity. B, three consecutive line scan images through the smooth muscle cell and an adjacent
nerve terminal varicosity shown in A. The arrow marks the time of the stimulus. The central panel is shown
again in C, but with greater temporal resolution around the time of the stimulus. D, quantification of the
changes in fluorescence from a region at the right edge of the smooth muscle cell and from the overlying
varicosity. E, magnified view, demonstrating that the [Ca2+] in the varicosity rises before that in the smooth
muscle cell.
action potentials at 1 Hz, despite being directly apposed to
a smooth muscle cell that responded to other varicosities
on the same nerve terminal branch (Fig. 1D and E). This
finding suggests that some varicosities have a very low
(possibly zero) probability of transmitter release. Given
the finite number of recordings, it can only be stated (with
95 % confidence) that the release probability from these
junctions is less than 0.006 (which is 1 _ 0.050.002).
Given that Ca2+ influx into the nerve terminal is necessary
to trigger transmitter release, it might be predicted that
there would be a positive correlation between the amplitude
of the [Ca2+]v transient evoked by the nerve action
potential and the probability of release from that
varicosity. When the amplitude of the [Ca2+]v transient in
response to the first action potential in a train at 1 Hz was
compared with the probability of detecting NCTs in the
adjacent smooth muscle during the train, no significant
correlation was detected (95 % confidence interval for
correlation coefficients of –0.77 to 0.06; nc = 16; np = 4).
Impulse-to-impulse monitoring of the [Ca2+]v transient
amplitude was not carried out, as the [Ca2+]v does not
completely return to its resting concentration between
stimuli during trains of impulses at 1 Hz. As the
fluorescence of the high-affinity indicator Oregon Green
488 BAPTA-1 is not proportional to the change in [Ca2+]v
over a large range, analysis of the amplitude of the
fluorescence signal change following each impulse in a
train of impulses cannot be interpreted with any degree of
confidence.
Kinetics of NCTs
When recorded with a temporal resolution of 214 ms, the
NCTs showed a peak [Ca2+]sm on the first frame after the
stimulus, which thereafter rapidly returned to the resting
concentration. When sampled between 50 and 100 ms after
the stimulus, the NCTs extended over an area of
12 ± 2 mm2 (defined as the area in which the change in
fluorescence signal was greater than 1/e of its maximum;
nc = 4; nsm = 3; np = 3). As each NCT is bounded and
constrained by the plasma membrane on one side, the
shape of the NCT is approximately hemispherical or
circular (with a radius of 2.8 ± 0.2 mm). NCTs could also be
detected with a Nipkow disc-scanning microscope (20 ms
temporal resolution; nsm = 4; np = 1; data not shown).
In order to study the kinetics of NCTs at a greater temporal
resolution, line scanning confocal microscopy was
performed. Line scans (1 ms resolution) through regions of
smooth muscle cells generating NCTs confirmed that the
[Ca2+]sm rises close to the plasma membrane and then
diffuses further into the smooth muscle cell (Fig. 3). When
the adjacent nerve terminal varicosity lay along the axis of the
line scan, the [Ca2+]v increase always preceded the NCT.
When the fluorescence signal from within 2 mm of the edge
of the smooth muscle cell was measured, there was a delay
between the stimulus and the first detectable increase in
[Ca2+]sm of 6.0 ± 1.3 ms (nc = 8; np = 4). This delay reflects
the time for action potential propagation in the nerve,
junctional delay and the time for the [Ca2+]sm to rise to a
detectable concentration. The time-to-peak of the NCTs was
30 ± 2 ms (nc = 8; np = 4). The fluorescence then recovered
with first-order kinetics with a time constant of 120 ± 19 ms
(nc = 8; np = 4). When the kinetics of NCTs were monitored
during xy-scanning over an area of 20–60 mm2, the NCTs
recovered with first-order kinetics with a time constant of
280 ± 90 ms (nc = 7; np = 4). The large difference between
these two time constants suggests that diffusion of Ca2+ into
the smooth muscle cytoplasm contributes to recovery of the
[Ca2+] close to the site of entry.
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Figure 4. NCTs occur spontaneously at a low frequency
A, spontaneous focal [Ca2+] transients (*) are occasionally recorded (frame 2). These spontaneous focal
[Ca2+] transients are similar to evoked NCTs (frame 5), in this case arising adjacent to an indicator-filled
varicosity. These images were acquired during a long train of stimuli at high frequency (2.3 Hz), during
which the [Ca2+]v accumulated to such an extent that the indicator begins to be saturated and hence the
action potential-induced change in [Ca2+]v is not apparent. B, a smooth muscle cell and an adjacent nerve
terminal varicosity (arrow) are shown in a series of confocal images. The [Ca2+] in the varicosity rises to a
plateau and is associated with spontaneous NCTs at t = 1 and 5 s. Hence spontaneous nerve terminal [Ca2+]
transients are sometimes associated with local, spontaneous ATP release.
Does the amplitude of NCTs vary at a single
neuroeffector junction?
It is generally believed that each vesicle releases a similar
number of transmitter molecules, i.e. that the quantal size
is similar. If the change in [Ca2+]sm is proportional to the
amount of ATP released, then the amplitude of each NCT
should vary over a small range from the mean at a given
neuroeffector junction. However, during xy-scanning the
amplitude of NCTs at a given site was found to vary more
than 9-fold (nc = 6; nsm = 3; np = 3). The variance of the
amplitude distribution was much greater than the variance
of the noise (F-test P value of < 0.0001 at each neuro-
effector junction; nc = 6; nsm = 3; np = 3), which suggests
that the recording method was not entirely responsible for
the wide range of NCT amplitudes from a given junction.
Spontaneous NCTs
As the evoked release of ATP generates NCTs, it was
intriguing to discover whether spontaneous transmitter
release could similarly be detected. Spontaneous focal
[Ca2+]sm transients were occasionally observed. These focal
[Ca2+]sm transients usually occurred (80 % of the time) in
the same location as evoked NCTs (Fig. 4A) and were
abolished by a,b-methylene ATP (1 mM; nsm = 8; np = 4).
They are likely to result from the spontaneous release of
packets of ATP from nerve terminal varicosities and will be
referred to as spontaneous NCTs (sNCTs). Such sNCTs
had amplitudes that were within the range of the
amplitudes of evoked NCTs from the same site. Precise
interpretation of the amplitude of the sNCTs is difficult
because the time between transmitter release and
recording is unknown and uncontrolled, while the
sampling interval (214 ms) is similar to the rate of decay of
sNCTs. sNCTs occurred with a frequency of 0.0014 Hz per
junction (range 0–0.02 Hz; nc = 259; nsm = 37; np = 22),
i.e. about one event every 12 min. The low frequency of
occurrence makes the study of sNCTs difficult at present.
Junctions that showed sNCTs had a slightly greater evoked
NCT probability than those showing no spontaneous
activity (DPNCT = 0.005 ± 0.001; nc = 259; nsm = 37; np = 22;
unpaired t test, P < 0.05).
In previous studies it has been reported that spontaneous
changes in [Ca2+]v lasting 1–10 s intermittently occurred in
a small subset of nerve terminal varicosities (Brain &
Bennett, 1997), and it has been speculated that such [Ca2+]v
transients might transiently increase the probability of
spontaneous transmitter release. In the present study,
similar slow [Ca2+]v transients were also observed. sNCTs
in the adjacent smooth muscle cells preferentially occurred
during these spontaneous [Ca2+]v transients (nsm = 4;
np = 4; Fig. 4B; Fisher’s exact test, P < 0.05 for each cell). In
each of these cells sNCTs were recorded rarely, so a
quantitative comparison of the probability of sNCTs, with
and without spontaneous [Ca2+]v transients, has not been
made. These observations suggest that spontaneous
elevations in [Ca2+]v sometimes precede, and therefore
presumably initiate, transmitter release.
Non-regenerative smooth muscle [Ca2+] waves
NCTs at a small minority of neuroeffector junctions
(nc = 4; nsm = 3; np = 3) characteristically initiated a [Ca
2+]sm
transient that propagated within the smooth muscle cell
over a distance of 5–10 mm, before collapsing within 0.6–1
s. This propagation was often unidirectional along the
longitudinal axis of the cell, with the direction consistent
among events arising from the same focus. Such uni-
directional propagation may be due to a local diffusion
barrier or due to the local and non-uniform triggering of
Ca2+ release from within the smooth muscle cell in a
manner that was subthreshold for maintaining regenerative
Ca2+ waves.
Local contraction
In some smooth muscle cells (nsm = 8 of a series of 38;
np = 7) NCTs initiated a twitch, demonstrating that local
transmitter release is capable of causing local contraction.
Independence of NCTs from adjacent junctions
NCTs are sufficiently small, compared with the distance
between varicosities on the same nerve terminal branch,
that when NCTs occur synchronously at adjacent
junctions, these NCTs can be resolved (Fig. 5A). This
ability to resolve synchronous NCTs indicates that the
measurement of transmitter release probabilities is not
underestimated simply by a failure to distinguish the
simultaneous release of transmitter from adjacent varicosities.
At some junctions, the occurrence of an NCT in one
smooth muscle cell was strongly correlated with the
simultaneous occurrence of an NCT in an adjacent smooth
muscle cell (Fig. 5B; Fisher’s exact P < 0.001; number of
pairs = 6; np = 4). The existence of such synchronous
NCTs strongly suggests that ATP, locally released from
one varicosity, can act on more than one smooth muscle
cell.
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Figure 5. NCTs from adjacent sites
A, selected images of two smooth muscle cells taken during a train
of 1 Hz stimuli (#), recorded at a frequency of 2 Hz. NCTs from
adjacent regions of the smooth muscle cell (frames 2 and 3) can be
resolved, even when they occur synchronously (frame 4). B, the
same two adjacent smooth muscle cells in which adjacent regions
show simultaneous NCTs (frame 2).
Effects of stimulus frequency on NCTs
Excitatory junction potentials and currents in the mouse
vas deferens, and many other tissues, show frequency-
dependent facilitation, so it was of interest to determine
whether an analogous increase in the probability of detecting
an NCT following nerve stimulation (PNCT) occurred as the
frequency of stimulation increased. PNCT at 1 Hz was
60 ± 20 % greater than when stimulating at 0.1 Hz
(Fig. 6A; nc = 64; nsm = 8; np = 5; P < 0.05), demonstrating
that there is frequency-dependent facilitation of
transmitter release as reported by the detection of NCTs.
It was of great interest to determine whether facilitation of
transmission occurred at all junctions and whether the
initial release probability from a given junction influenced
its capacity to facilitate. To distinguish between junctions
with a high or low probability of release (when stimulated
at 0.1 Hz), an arbitrary threshold probability of PNCT = 0.02
was chosen (which is close to the mean probability). Low
release probability junctions (PNCT ≤ 0.02 at 0.1 Hz)
showed an increase in PNCT of 130 ± 30 % (nc = 51) when
stimulated at 1 Hz. Higher release probability junctions
(PNCT > 0.02 at 0.1 Hz), however, showed only a 38 ± 16 %
increase in PNCT at 1 Hz (nc = 13). This difference in the
frequency dependence of PNCT between low (< 0.02) and
higher (> 0.02) release probability junctions is significant
(unpaired t test, P < 0.05), implying that frequency-
dependent facilitation of transmitter release preferentially
occurs from varicosities that initially have a low
probability of release. The results also suggest that most
functional neuroeffector junctions contribute to facilitation.
Local autoinhibition of transmitter release
Sympathetic neurotransmission is modulated by neurally
released NA acting at prejunctional a2-adrenoceptors. In
order to determine whether NA was locally released and to
investigate autoregulation with a high spatial resolution,
this pathway was interrupted using the competitivea2-adrenoceptor antagonist yohimbine. At 1 Hz, yohimbine
(10 mM) increased PNCT by 55 ± 21 % (Fig. 6B; nc = 35;
nsm = 4; np = 3; P < 0.05). The proportional increase in
PNCT was not significantly different between low and high
release probability junctions (unpaired two-tailed t test,
P = 0.66). These findings indicate that NA is released
locally and that both high and low release probability
junctions undergo a2-adrenoceptor-mediated auto-
inhibition.
Intermittent whole-cell increases in [Ca2+]sm
Some smooth muscle cells (nsm = 17; np = 12) exhibited
intermittent, whole-cell increases in [Ca2+]sm in response
to nerve stimulation (Fig. 7). In these cells, the average
probability of occurrence of whole-cell [Ca2+]sm transients
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Figure 6. Facilitation and autoinhibition of NCTs
A, NCT probability in response to trains of stimuli at 1 Hz,
compared with 0.1 Hz stimulation, in 6 preparations, following
more than 200 stimuli with each protocol. Each point represents
one neuroeffector junction. The NCT probabilities, when
stimulated at 0.1 and 1 Hz, were positively correlated (correlation
coefficient 0.84; 95 % confidence interval 0.77 –0.89). Those
junctions with a lower initial release probability show more
facilitation. The continuous lines are linear curve fits to the data
when PNCT < 0.02 at 0.1 Hz, and when PNCT > 0.35 at 0.1 Hz. The
dashed line is where the two probabilities are equal. B, in the
presence of the a2-antagonist yohimbine (10 mM) during 1 Hz
stimulation, however, there is a more uniform elevation in release
probability, demonstrating that locally released endogenous NA
modulates ATP release from most secretory varicosities. There was
a positive correlation between PNCT in the control and in the
presence of yohimbine (correlation coefficient 0.87; 95 %
confidence interval 0.76–0.93).
Figure 7. Intermittent whole-cell [Ca2+] transients
Whole-cell [Ca2+] increases (*) are intermittently evoked in some
smooth muscle cells. These events can be used to detect smooth
muscle action potentials.
following a single nerve terminal action potential was
0.029 ± 0.009 (nsm = 9; np = 7). These whole-cell [Ca
2+]sm
elevations could be abolished by either a,b-methylene
ATP (1 mM; nsm = 2; np = 1) or nifedipine (1 mM; nsm = 5;
np = 4). No pairs of nearby smooth muscle cells were
found in which whole-cell increases in [Ca2+]sm
synchronously occurred at a rate greater than that predicted
by chance.
DISCUSSION
Neuroeffector Ca2+ transients are generated as a result
of local ATP release from nerve terminal varicosities
The present work has established a technique for detecting
and monitoring the release of transmitter with high spatial
resolution by using postjunctional smooth muscle cells as
a biological detector. The occurrence of focal [Ca2+]sm
transients following field stimulation, their clustering and
the observation that such events are abolished when the
nerve terminal action potential is abolished (with
saxitoxin), imply that they are generated by the release of
transmitter from nerve terminals. The clustering of NCTs
and their frequent apposition to nerve terminal
varicosities strongly suggests that they are generated by the
discrete release of transmitter from varicosities that
presumably make close contact with the smooth muscle
cell. This is the first direct evidence for the release of
transmitter from varicosities rather than inter-varicose
segments.
The changes in [Ca2+] in the smooth muscle cells and nerve
terminal varicosities can be clearly distinguished because
the former: (1) are abolished by  a,b-methylene ATP;
(2) occur within a smooth muscle cell, identified on the
basis of its size and shape; (3) are highly intermittent rather
than occurring without failure; (4) occur over a much
larger area (12 ± 2 mm2 compared with the 1–2 mm2
reported by Brain & Bennett, 1997); (5) occur at a later
time after the stimulus (during line scanning); and (6) do
not have sharply demarked boundaries, except at the
boundary of the smooth muscle cell.
NCTs arise following the activation of P2X receptors
(Fig. 8), as they were abolished by prolonged exposure to
the P2X receptor agonist a,b-methylene ATP (1 mM),
which desensitises P2X receptors and induces receptor
internalisation (Ennion & Evans, 2001). Focal [Ca2+]
transients, occurring in response to exogenous ATP acting
on P2X receptors, have been previously reported in rat
isolated portal vein smooth muscle cells (Mironneau et al.
2001), but there have been no similar studies on endo-
genous ATP release in intact organs. Purinergic transmission
in the guinea-pig bladder induces Ca2+ waves that
propagate between bundles of smooth muscle cells
(Hashitani et al. 2000), but it is not known whether these
waves are preceded by more focal Ca2+ transients.
Activation of a1-adrenoceptors was not involved in
generating NCTs, as the NCTs were not affected by
prazosin (100 nM). The varicosities from which these
purinergic NCTs originate are probably sympathetic, as
vasa deferentia taken from mice pretreated with
6-hydroxydopamine do not have purinergic excitatory
junction potentials (Allcorn et al. 1986).
NCTs do not depend on the influx of Ca2+ through L-type
voltage-gated Ca2+ channels, which are the only significant
high-voltage-activated Ca2+ channels found on smooth
muscle cells (Knöckner, 1996), as nifedipine (1 mM) had
no effect on them. The lack of effect of nifedipine is
consistent with the observation that nifedipine does not
affect excitatory junction potentials in the vas deferens
(Beattie et al. 1986; Stjärne et al. 1991). While we have not
tested for a potential contribution from T-type (low-
voltage-activated) Ca2+ channels, it is unlikely that
depolarisation can be sufficiently spatially confined to
yield local depolarisation within a few square micrometres
of smooth muscle cell membrane without similarly
depolarising the rest of the smooth muscle cell. Whether or
not intracellular Ca2+ stores are involved in amplifying the
Ca2+ influx through P2X receptors is at present under
investigation.
The confocal microscope has sufficient spatial resolution
to distinguish between release from adjacent varicosities
on the same nerve terminal branch. Given that the NCTs
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Figure 8. A schematic illustrating the intermittent release
of ATP, which generates NCTs
Each nerve terminal action potential invades every varicosity, but a
packet of ATP, and presumably NA, is only rarely released. The
ATP acts on P2X receptors, triggering the entry of Ca2+. Locally
released NA mediates prejunctional autoinhibition.
have a radius of 2.8 ± 0.2 mm at the time they have been
sampled and that the length of a varicosity is about 1 mm
(Cottee et al. 1996), the current studies do not allow us to
determine whether or not there is more than one active
zone in each varicosity.
Intermittence of transmitter release
The intermittence of NCTs, and hence transmitter release,
might be due to intermittent failure of action potential
propagation in the nerve terminal. However, in
preparations where both the varicose nerve terminals and
the smooth muscle cells were labelled, the action potential-
evoked [Ca2+]v transient occurred in response to every
stimulus, confirming that intermittence of release is not
due to failure of action potential propagation in the axon
or secretory nerve terminals (Brock & Cunnane, 1988;
Brain & Bennett, 1997; Jackson et al. 2001).
The measurement of postsynaptic [Ca2+] as a tool to
determine release probability has recently been used in the
dendritic spines of hippocampal neurons (Emptage et al.
1999; Kovalchuk et al. 2000). To our knowledge there have
been no previous studies of simultaneous presynaptic (or
prejunctional) and postsynaptic (or postjunctional) [Ca2+]
with the resolution to detect transmitter release from
sequential strings of individual varicosities or boutons on
the same nerve terminal branch.
The probability of transmitter release reported in the
present study (0.001–0.1; median 0.01; mean 0.019 ± 0.002)
is consistent with early estimates from transmitter
overflow studies of 0.01–0.03 (Folkow et al. 1967), and
very similar to probabilities determined from ‘discrete
events’ (0.002–0.03; Cunnane & Stjärne, 1984). These
release probabilities are, however, considerably lower than
those determined from measurement of focal extracellular
currents (mean of 0.25; Lavidis & Bennett, 1992).
Transmitter release from a single varicosity has been
recorded on one occasion from one site, when excitatory
junctional currents were recorded with an electrode of
very small tip size and the nerve terminal varicosities were
labelled with 3-3-diethyloxardicarbocyanine iodide (Lavidis
& Bennett, 1992). Their experiment yielded a probability
of transmitter release of 0.12 for this varicosity, in a bath
Ca2+ concentration of 4 mM and Mg2+ concentration of
1.2 mM. However, under most recording conditions focal
extracellular electrodes do not have sufficient spatial
resolution to distinguish transmitter release from nearby
nerve terminal varicosities in this preparation.
One reasonable concern is that the presence of a Ca2+
indicator in the nerve terminal could affect the probability
of release. One can test this hypothesis by comparing the
PNCT of varicosities that contained the indicator with those
that did not. In the present experiments there was no
significant difference in PNCT from neuroeffector junctions
where the indicator was present in the varicosity, compared
with those where it was not (i.e. where the varicosity could
not be seen). This suggests that the concentration of the
Ca2+ indicator in labelled nerve terminals was insufficient
to modify transmitter release. However, there can be no
doubt that a high intraterminal concentration of fast Ca2+
buffers can decrease the probability of exocytosis from
sympathetic nerve terminals, at least in the guinea-pig vas
deferens (Hardy & Brock, 2001).
Some varicosities failed to generate adjacent NCTs, even
though they responded to nerve terminal action potentials
with a rise in [Ca2+]v, and were on a nerve terminal branch
where other varicosities elicited NCTs. These failures may
reflect an extremely low (or zero) release probability from
these varicosities, or it may be that the regions of the
smooth muscle cells adjacent to these varicosities were
insensitive to ATP. The latter hypothesis is possible as P2X
receptors may not be uniformly distributed over the
surface of smooth muscle cells. In the mouse vas deferens it
has been reported that P2X receptors cluster adjacent to
nerve terminals (Barden et al. 1999), while in the rat vas
deferens, dopamine b-hydroxylase-labelled structures are
sometimes juxtaposed to P2X receptor clusters (Vulchanova
et al. 1996). Other authors have found no significant clustering
of receptors under nerve terminal varicosities in the mouse
vas deferens (Liang et al. 2001). The present work cannot
determine whether P2X receptor clusters occur in mouse
vas deferens. If receptor clusters exist, then the size of
NCTs implies that, under most circumstances, only one
P2X receptor cluster on a given smooth muscle cell is
activated following transmitter release. If there are no
receptor clusters, then the size of NCTs suggests that only
those P2X receptors within a few micrometres of the
release site are activated following transmitter release.
It is possible that some varicosities released ATP, but there
were no nearby P2X receptors and hence no NCT was
generated. This requirement for functional P2X receptors
is also shared by other experimental methods that measure
transmitter release, including intracellular and focal extra-
cellular recording. Hence these experimental approaches
do not measure transmitter release per se, but rather trans-
mitter release from sites that are functionally coupled to
smooth muscle cells.
The probability of occurrence of NCTs varies along the
length of a nerve terminal (Fig. 1E), as does the probability
of occurrence of excitatory junctional currents (Lavidis &
Bennett, 1992, 1993). The amplitude of [Ca2+]v transients
in response to single action potentials has been reported to
vary significantly among varicosities on the same branch
(while [Ca2+]v transients from a given varicosity are more
consistent), and it has been hypothesised that those
varicosities with a high amplitude [Ca2+]v transient might
have a high release probability (Brain & Bennett, 1997). This
hypothesis is also supported by the supralinear relationship
between extracellular [Ca2+] and release probability in the
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mouse vas deferens (Macleod et al. 1994). In the present
work, there was no correlation between the amplitude of
the [Ca2+]v transient following the first stimulus in a train
and the subsequent probability of NCTs in the adjacent
smooth muscle cell. Thus the amplitude of the first [Ca2+]v
transient in a train is not a reliable determinant of what the
probability of transmitter release from a given varicosity
will be.
It is interesting to note that only 20 % of cells had
neuroeffector junctions in which some NCTs were able to
initiate a local twitch. This finding suggests that the release
of transmitter from a single varicosity does not inevitably
trigger contraction of the cell it innervates, despite the
local [Ca2+]sm transient. The whole organ twitch following
single impulses or short trains of impulses is augmented by
the flux of Ca2+ through L-type Ca2+ channels as nifedipine
reduces, but does not abolish, this component of contraction
in the mouse vas deferens (Rae & Calixto, 1989).
Spontaneous transmitter release
Sympathetic varicosities release transmitter in the absence
of stimulation, detected by the measurement of spontaneous
excitatory junction potentials (SEJPs; Burnstock &
Holman, 1961). In the present inquiry, the frequency of
discrete [Ca2+]sm elevations that were not preceded by a
stimulus (sNCTs) was very low (about one every 12 min).
It was also found that the frequency of sNCTs was weakly
correlated with the probability of evoked transmitter
release from the same site. This may reflect the presence of
some varicosities with either a large number of vesicles or a
greater proportion of vesicles available for both evoked
and spontaneous transmitter release.
The origin of slow, spontaneous [Ca2+]v transients (Brain &
Bennett, 1997) has not been determined. Similar [Ca2+]v
transients were also noted in the present study. These [Ca2+]v
transients were occasionally associated with sNCTs in the
adjacent smooth muscle cell, which implies that
spontaneous transmitter release is sometimes associated
with spontaneous [Ca2+]v transients. It is unlikely that these
spontaneous transients cause an increase in the whole
varicosity [Ca2+] that is sufficient to directly trigger
exocytosis, as their mean amplitude has been estimated at
120 nM (Brain & Bennett, 1997). It is quite possible that there
are associated focal increases in [Ca2+] that trigger exocytosis,
but these cannot be spatially resolved with light microscopy
or detected with a high-affinity Ca2+ indicator. Alternatively,
it is possible that a prolonged elevation in [Ca2+]v increases
the probability of spontaneous exocytosis by a mechanism
similar to that proposed for the residual Ca2+ hypothesis for
short-term facilitation (Zucker, 1989, 1999).
A single packet of ATP acts on more than one
smooth muscle cell
NCT detection was strongly correlated between some pairs
of adjacent smooth muscle cells. The most likely explanation
is that a packet of ATP released from one varicosity can act
upon receptors on adjacent cells. It is unlikely that Ca2+
rapidly diffused through local gap junctions, as the
amplitudes of synchronous NCTs in such adjacent cells
were similar. The synchronicity of such NCT doublets
implies that even though smooth muscle cells may possess
postjunctional specialisations for purinergic transmission
(Vulchanova et al. 1996; Barden et al. 1999), more than
one such specialisation may be associated with each putative
prejunctional specialisation. Hence a ‘neuromuscular
junction’ in the vas deferens can involve more than one
smooth muscle cell.
Facilitation depends on the basal release probability
During short trains of nerve terminal action potentials, the
probability of transmitter release increases (Burnstock
et al. 1964; Bennett & Florin, 1975) until a steady state is
reached. Whether this facilitation of transmitter release is
due to an increase in the release probability from all
varicosities, or whether there is preferential recruitment of
low probability (or silent) varicosities, was unknown. In
the present study, junctions with a low probability of
release (≤ 0.02) exhibited more facilitation than those with
a higher (> 0.02) probability. Hence low probability release
sites facilitate more than high probability release sites, even
though the probability of release remains much less than
one, and indeed less than 0.1. In future studies, it will be of
great interest to investigate facilitation of transmitter
release at higher frequencies of nerve stimulation.
Noradrenaline and autoinhibition
It is perhaps surprising that NCTs are solely generated by
the release of ATP, and that at present we cannot detect any
local [Ca2+]sm transient attributable to NA. NA and ATP
are generally thought to be co-released as they are found in
the same vesicles (Fried, 1980) and the overflow of these
transmitters from autonomically innervated tissues following
nerve stimulation is similar (Westfall et al. 1978; but see
Stjärne, 2001).
One of the effects of locally released NA is the inhibition of
subsequent transmitter release by action at prejunctionala2-adrenoceptors (Illes & Starke, 1983). In the present
study, it was found that the a2-adrenoceptor antagonist
yohimbine increased the probability of occurrence of
NCTs during trains of stimuli at 1 Hz. This finding implies
that NA was released from, or close to, the nerve terminal
varicosities that generate purinergic NCTs. The similar
increase in release probabilities among all release sites
suggests that all secretory varicosities are exposed to a
similar pool of NA and are equipped with functionala2-mediated inhibitory mechanisms.
Smooth muscle [Ca2+] transients during noradrenergic
transmission in intact tissues have been previously reported
in the rat tail artery (Iino et al. 1994), while there are many
reports of smooth muscle Ca2+ transients in response to
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exogenously applied adrenoceptor agonists (for example,
see Mauban et al. 2001) in preparations including the
guinea-pig vas deferens (Kato et al. 2000). In the rat tail
artery, noradrenergic transmission evoked by field
stimulation elicits waves and oscillation of the [Ca2+]sm
within the smooth muscle cell (Iino et al. 1994). No such
Ca2+ transients were observed in the present study, at
stimulus frequencies of 5 Hz and below, even in the
presence of desmethylimipramine, which blocks the
catecholamine transporter uptake-1. It may be that the
subset of cells loaded with the Ca2+ indicator are amongst a
minority of cells which fail to respond to NA, that the
stimulus was subthreshold for the generation of Ca2+
waves, or that the mouse vas deferens differs from other
smooth muscle cells in the mechanisms by which NA
causes contraction.
The most commonly used explanation for excitation–
contraction coupling in smooth muscle cells is an increase
in intracellular [Ca2+]sm through either L-type Ca
2+
channels or the release of Ca2+ from intracellular stores
(Berridge, 1993). However, there is apparently little
contribution to NA-induced contraction from intra-
cellular stores in the vas deferens, at least in the rat, as
perturbing intracellular Ca2+ stores with ryanodine,
cyclopiazonic acid or thapsigargin had little effect on NA-
induced contraction (Amobi et al. 1999). Smooth muscle
contraction that is independent of an increase in [Ca2+]sm
has previously been reported and appears to involve an
increase in the sensitivity of the contractile apparatus to
Ca2+ (Collins et al. 1992; Morgan et al. 1992), which may
involved a Rho-kinase-mediated pathway (Somlyo &
Somlyo, 2000).
Smooth muscle action potentials
In some cells, evoked, low amplitude, whole-cell increases
in [Ca2+]sm were intermittently detected. These were
abolished by either nifedipine (1 mM) or a,b-methylene
ATP (1 mM), suggesting that such transients arise when
purinergic neurotransmission triggers a smooth muscle
action potential. While most smooth muscle cells display
Ca2+ action potentials (see Kuriyama et al. 1982; Hirst et al.
1986; Mostwin, 1986; Lang et al. 1998), smooth muscle
action potentials in the mouse vas deferens are mediated
by fast voltage-gated Na+ channels (Holman et al. 1977,
1995). It is likely that the whole-cell increases in [Ca2+]sm
reported in the present study are generated when the
smooth muscle cell is depolarised by the Na+ action
potentials. The depolarisation triggers an influx of Ca2+
through L-type Ca2+ channels, causing an increase in
[Ca2+]sm. It is not possible to confirm that the whole-cell
[Ca2+]sm transients arise following Na
+ action potentials by
blocking voltage-gated Na+ channels, as this intervention
abolishes the nerve terminal action potential and hence
transmitter release.
If the smooth muscle cells of the mouse vas deferens are
electrically coupled, one would expect to find nearby pairs
of smooth muscle cells with synchronous smooth muscle
action potentials. As no such pairs of smooth muscle cells
were found, it may be that smooth muscle cells that fire
action potentials are electrically isolated from surrounding
cells, as has previously been suggested for the mouse vas
deferens (Blakeley et al. 1989). As only a small proportion
of smooth muscle cells were labelled in any one preparation,
we cannot rule out the existence of weak electrical
coupling.
Conclusions
The approach described here provides a high-resolution
method to study simultaneously, on an impulse-to-
impulse basis, intravaricosity [Ca2+] and the intermittent
release of ATP from individual varicosities on the same
nerve terminal branch. By counting the action potential-
evoked, packeted release of ATP, this approach now allows
the physiology and pharmacology of autonomic trans-
mission to be explored with a degree of resolution
previously unobtainable. The detection of local smooth
muscle [Ca2+] transients following purinergic transmission
suggests that Ca2+ flux thought P2X receptors may
contribute to the purinergic ‘twitch’ component of
contraction in smooth muscle.
REFERENCES
ALLCORN, R. J., CUNNANE, T. C. & KIRKPATRICK, K. (1986). Actions ofa,b-methylene ATP and 6-hydroxydopamine on sympathetic
neurotransmission in the vas deferens of the guinea-pig, rat and
mouse: support for cotransmission. British Journal of
Pharmacology 89, 647–659.
AMOBI, N. I., SUGDEN, D. & SMITH, I. C. (1999). Pharmacomechanical
coupling in rat vas deferens: effects of agents that modulate
intracellular release of calcium and protein kinase C activation.
Life Sciences 65, 145–156.
BARDEN, J. A., COTTEE, L. J. & BENNETT, M. R. (1999). Vesicle-
associated proteins and P2X receptor clusters at single sympathetic
varicosities in mouse vas deferens. Journal of Neurocytology 28,
469–480.
BEATTIE, D. T., CUNNANE, T. C. & MUIR, T. C. (1986). Effects of
calcium channel antagonists on action potential conduction and
transmitter release in the guinea-pig vas deferens. British Journal of
Pharmacology 89, 235–244.
BENHAM, C. D. & TSIEN, R. W. (1987). A novel receptor-operated
Ca2+-permeable channel activated by ATP in smooth muscle.
Nature 328, 275–278.
BENNETT, M. R. & FLORIN, T. (1975). An electrophysiological analysis
of the effect of Ca ions on neuromuscular transmission in the
mouse vas deferens. British Journal of Pharmacology 55, 97–104.
BERRIDGE, M. J. (1993). Inositol trisphosphate and calcium
signalling. Nature 361, 315–325.
BLAKELEY, A. G., DUNN, P. M. & PETERSEN, S. A. (1989). Properties of
excitatory junction potentials and currents in smooth muscle cells
of the mouse vas deferens. Journal of the Autonomic Nervous
System 27, 47–56.
K. L. Brain, V. M. Jackson, S. J. Trout and T. C. Cunnane860 J. Physiol. 541.3
BRAIN, K. L. & BENNETT, M. R. (1997). Calcium in sympathetic
varicosities of mouse vas deferens during facilitation,
augmentation and autoinhibition. Journal of Physiology 502,
521–536.
BRAIN, K. L., TROUT, S. J., JACKSON, V. M., DASS, N. & CUNNANE, T. C.
(2001). Nicotine induces calcium spikes in single nerve terminal
varicosities: A role for intracellular calcium stores. Neuroscience
106, 395–403.
BROCK, J. A. & CUNNANE, T. C. (1987). Relationship between the
nerve action potential and transmitter release from sympathetic
postganglionic nerve terminals. Nature 326, 605–607.
BROCK, J. A. & CUNNANE, T. C. (1988). Electrical activity at the
sympathetic neuroeffector junction in the guinea-pig vas deferens.
Journal of Physiology 399, 607–632.
BROWN, G. L. & GILLESPIE, J. S. (1957). The output of sympathetic
transmitter from the spleen of the cat. Journal of Physiology 138,
81–102.
BURNSTOCK, G. (1976). Do some nerve cells release more than one
neurotransmitter? Neuroscience 1, 239–248.
BURNSTOCK, G. & HOLMAN, M. E. (1961). The transmission of
excitation from autonomic nerve to smooth muscle. Journal of
Physiology 155, 115–133.
BURNSTOCK, G., HOLMAN, M. E. & KURIYAMA, H. (1964). Facilitation
of transmission from autonomic nerves to smooth muscle of
guinea-pig vas deferens. Journal of Physiology 172, 31–49.
COLLINS, E. M., WALSH, M. P. & MORGAN, K. G. (1992). Contraction
of single vascular smooth muscle cells by phenylephrine at
constant CaA. American Journal of Physiology 262, H754–762.
COTTEE, L. J., LAVIDIS, N. A. & BENNETT, M. R. (1996). Spatial
relationships between sympathetic varicosities and smooth muscle
cells in the longitudinal layer of the mouse vas deferens. Journal of
Neurocytology 25, 413–425.
CUNNANE, T. C. & STJÄRNE, L. (1984). Transmitter secretion from
individual varicosities of guinea-pig and mouse vas deferens:
highly intermittent and monoquantal. Neuroscience 13, 1–20.
EMPTAGE, N., BLISS, T. V. P. & FINE, A. (1999). Single synaptic events
evoke NMDA receptor-mediated release of calcium from internal
stores in hippocampal dendritic spines. Neuron 22, 115–124.
ENNION, S. J. & EVANS, R. J. (2001). Agonist-stimulated
internalisation of the ligand-gated ion channel P2X(1) in rat vas
deferens. FEBS Letters 489, 154–158.
FOLKOW, B., HÄGGENDAL, J. & LISANDER, B. (1967). Extent of release
and elimination of noradrenaline at peripheral adrenergic nerve
terminals. Acta Physiologica Scandinavica, suppl. 307, 1–38.
FRIED, G. (1980). Small noradrenergic storage vesicles isolated from
rat vas deferens –  biochemical and morphological
characterization. Acta Physiologica Scandinavica, suppl. 493, 1–28.
HARDY, T. A. & BROCK, J. A. (2001). Effects of modulating Ca2+ entry
and activating prejunctional receptors on facilitation of excitatory
junction potentials in the guinea-pig vas deferens in vitro.
Naunyn–Schmiedeburg’s Archives of Pharmacology 363, 515–525.
HASHIMOTO, T., HIRATA, M., ITOH, T., KANMURA, Y. & KURIYAMA, H.
(1986). Inositol 1, 4, 5-trisphosphate activates
pharmacomechanical coupling in smooth muscle of the rabbit
mesenteric artery. Journal of Physiology 370, 605–618.
HASHITANI, H., BRAMICH, N. J. & HIRST, G. D. (2000). Mechanisms of
excitatory neuromuscular transmission in the guinea-pig urinary
bladder. Journal of Physiology 524, 565–579.
HIRST, G. D., SILVERBERG, G. D. & VAN HELDEN, D. F. (1986). The
action potential and underlying ionic currents in proximal rat
middle cerebral arterioles. Journal of Physiology 371, 289–304.
HOLMAN, M. E., TAYLOR, G. S. & TOMITA, T. (1977). Some properties
of the smooth muscle of mouse vas deferens. Journal of Physiology
266, 751–764.
HOLMAN, M. E., TONTA, M. A., PARKINGTON, H. C. & COLEMAN, H. A.
(1995). Tetrodotoxin-sensitive action potentials in smooth muscle
of mouse vas deferens. Journal of the Autonomic Nervous System 52,
237–240.
IINO, M., KASAI, H. & YAMAZAWA, T. (1994). Visualization of neural
control of intracellular Ca2+ concentration in single vascular
smooth muscle cells in situ. EMBO Journal 13, 5026–5031.
ILLES, P. & STARKE, K. (1983). An electrophysiological study of
presynaptic a-adrenoceptors in the vas deferens of the mouse.
British Journal of Pharmacology 78, 365–373.
JACKSON, V. M., TROUT, S. J., BRAIN, K. L. & CUNNANE, T. C. (2001).
Characterization of action potential-evoked calcium transients in
mouse postganglionic sympathetic axon bundles. Journal of
Physiology 537, 3–16.
KATO, K., FURUYA, K., TSUTSUI, I., OZAKI, T. & YAMAGISHI, S. (2000).
Cyclic AMP-mediated inhibition of noradrenaline-induced
contraction and Ca2+ influx in guinea-pig vas deferens.
Experimental Physiology 85, 387–398.
KNÖCKNER, U. (1996). Voltage-dependent L-type calcium channels
in smooth muscle cells. In Smooth Muscle Excitation,
ed. BOLTON, T. B. & TOMITA, T., pp. 1–12. Academic Press,
London.
KOVALCHUK, Y., EILERS, J., LISMAN, J. & KONNERTH, A. (2000). NMDA
receptor-mediated subthreshold Ca2+ signals in spines of
hippocampal neurons. Journal of Neuroscience 20, 1791–1799.
KURIYAMA, H., ITO, Y., SUZUKI, H., KITAMURA, K. & ITOH, T. (1982).
Factors modifying contraction-relaxation cycle in vascular smooth
muscles. American Journal of Physiology 243, H641–662.
LANG, R. J., EXINTARIS, B., TEELE, M. E., HARVEY, J. & KLEMM, M. F.
(1998). Electrical basis of peristalsis in the mammalian upper
urinary tract. Clinical and Experimental Pharmacology and
Physiology 25, 310–321.
LAVIDIS, N. A. & BENNETT, M. R. (1992). Probabilistic secretion of
quanta from visualized sympathetic nerve varicosities in mouse
vas deferens. Journal of Physiology 454, 9–26.
LAVIDIS, N. A. & BENNETT, M. R. (1993). Probabilistic secretion of
quanta from successive sets of visualized varicosities along single
sympathetic nerve terminals. Journal of the Autonomic Nervous
System 43, 41–50.
LIANG, S. X., MOTIN, L., MOUSSA, C. E. H., LAVIDIS, N. A. &
PHILLIPS, W. D. (2001). Spatial distribution and developmental
appearance of postjunctional P2X(1) receptors on smooth muscle
cells of the mouse vas deferens. Synapse 42, 1–11.
LOEWI, O. (1936). Quantitative und qualitative untersuchungen uber
den sympathicusstoff. Pflügers Archiv 237, 504–514.
MACLEOD, G. T., LAVIDIS, N. A. & BENNETT, M. R. (1994). Calcium
dependence of quantal secretion from visualized sympathetic
nerve varicosities on the mouse vas deferens. Journal of Physiology
480, 61–70.
MAUBAN, J. R., LAMONT, C., BALKE, C. W. & WIER, W. G. (2001).
Adrenergic stimulation of rat resistance arteries affects Ca2+ sparks,
Ca2+ waves, and Ca2+ oscillations. American Journal of Physiology –
Heart and Circulatory Physiology 280, H2399–2405.
MERMET, C., GONON, F. G. & STJÄRNE, L. (1990). On-line
electrochemical monitoring of the local noradrenaline release
evoked by electrical stimulation of the sympathetic nerves in
isolated rat tail artery. Acta Physiologica Scandinavica 140,
323–329.
Neuroeffector Ca2+ transientsJ. Physiol. 541.3 861
MIRONNEAU, J., COUSSIN, F., MOREL, J. L., BARBOT, C.,
JEYAKUMAR, L. H., FLEISCHER, S. & MIRONNEAU, C. (2001). Calcium
signalling through nucleotide receptor P2X1 in rat portal vein
myocytes. Journal of Physiology 536, 339–350.
MORGAN, K. G., KHALIL, R. A., SUEMATSU, E. & KATSUYAMA, H. (1992).
Calcium-dependent and calcium-independent pathways of signal
transduction in smooth muscle. Japanese Journal of Pharmacology
58, 247–253P.
MORRIS, J. L. & GIBBINS, I. L. (1992). Co-transmission and
neuromodulation. In Autonomic Neuroeffector Mechanisms,
ed. BURNSTOCK, G. & HOYLE, C. H. V., pp. 33–119. Harwood
Academic, Switzerland.
MOSTWIN, J. L. (1986). The action potential of guinea-pig bladder
smooth muscle. Journal of Urology 135, 1299–1303.
MULRYAN, K., GITTERMAN, D. P., LEWIS, C. J., VIAL, C., LECKIE, B. J.,
COBB, A. L., BROWN, J. E., CONLEY, E. C., BUELL, G.,
PRITCHARD, C. A. & EVANS, R. J. (2000). Reduced vas deferens
contraction and male infertility in mice lacking P2X1 receptors.
Nature 403, 86–89.
PEART, W. S. (1949). The nature of splenic sympathin. Journal of
Physiology 108, 491–501.
RAE, G. A. & CALIXTO, J. B. (1989). Interactions of calcium
antagonists and the calcium channel agonist Bay K 8644 on
neurotransmission of the mouse isolated vas deferens. British
Journal of Pharmacology 96, 333–340.
SOMLYO, A. P. & SOMLYO, A. V. (2000). Signal transduction by
G-proteins, Rho-kinase and protein phosphatase to smooth
muscle and non-muscle myosin II. Journal of Physiology 522,
177–185.
STJÄRNE, L. (1989). Basic mechanisms and local modulation of nerve
impulse-induced secretion of neurotransmitters from individual
sympathetic nerve varicosities. Reviews of Physiology, Biochemistry
and Pharmacology 137, 1121–1137.
STJÄRNE, L. (2001). Novel dual ‘small’ vesicle model of ATP- and
noradrenaline-mediated sympathetic neuromuscular
transmission. Autonomic Neuroscience: Basic and Clinical 87,
16–36.
STJÄRNE, L., STJÄRNE, E., MSGHINA, M. & BAO, J. X. (1991). K+ and
Ca2+ channel blockers may enhance or depress sympathetic
transmitter release via a Ca2+-dependent mechanism ‘upstream’ of
the release site. Neuroscience 44, 673–692.
VULCHANOVA, L., ARVIDSSON, U., RIEDL, M., WANG, J., BUELL, G.,
SURPRENANT, A., NORTH, R. A. & ELDE, R. (1996). Differential
distribution of two ATP-gated channels (P2X receptors)
determined by immunocytochemistry. Proceedings of the National
Academy of Sciences of the USA 93, 8063–8067.
WESTFALL, D. P., STITZEL, R. E. & ROWE, J. N. (1978). The
postjunctional effects and neural release of purine compounds in
the guinea-pig vas deferens. European Journal of Pharmacology 50,
27–38.
ZUCKER, R. S. (1989). Short-term synaptic plasticity. Annual Review
of Neuroscience 12, 13–31.
ZUCKER, R. S. (1999). Calcium- and activity-dependent synaptic
plasticity. Current Opinion in Neurobiology 9, 305–313.
Acknowledgements
K.L.B. is supported by an Oxford Nuffield Medical Fellowship;
S.J.T. is supported by The Wellcome Trust.
Supplementary material
The online version of this paper can be found at:
http://www.jphysiol.org/cgi/content/full/541/3/849
and contains supplementary material entitled:
Neuroeffector Ca2+ transients. The left panel shows consecutive
confocal images of part of a smooth muscle cell within an intact
mouse vas deferens during field stimulation. The sampling
frequency was 4 Hz; the stimulus (#) frequency was 2 Hz. The
right panel shows a cumulative map of the focal [Ca2+]sm
transients, here termed Neuroeffector Ca2+ Transients (NCTs).
Moving the plane of focus by 3 mm revealed an overlying varicose
nerve terminal. Each nerve terminal varicosity aligns well with a
cluster of NCTs, the locations of occurrence of which are marked
with dots.
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